Chapter 9. Induction and Maintenance Immunosuppression

  1. Richard N. Fine MD Dean Distinguished Professor of Pediatrics1,
  2. Steven A. Webber MBChB, MRCP Professor of Pediatrics2,
  3. Kim M. Olthoff MD, FACS Associate Professor of Surgery Director3,
  4. Deirdre A. Kelly MD, FRCPI, FRCP, FRCPCH Professor of Paediatric Hepatology4 and
  5. William E. Harmon MD Professor of Pediatrics5
  1. William E. Harmon MD Professor of Pediatrics

Published Online: 5 MAY 2009

DOI: 10.1002/9781444312720.ch9

Pediatric Solid Organ Transplantation, Second Edition

Pediatric Solid Organ Transplantation, Second Edition

How to Cite

Harmon, W. E. (2007) Induction and Maintenance Immunosuppression, in Pediatric Solid Organ Transplantation, Second Edition (eds R. N. Fine, S. A. Webber, K. M. Olthoff, D. A. Kelly and W. E. Harmon), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444312720.ch9

Editor Information

  1. 1

    Stony Brook University School of Medicine, Stony Brook, New York 11794-8111, USA

  2. 2

    University of Pittsburgh School of Medicine, Division of Cardiology, Children's Hospital, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA

  3. 3

    Liver Transplant Program, University of Pennsylvania and the Children's Hospital of Philadelphia, 2 Dulles, 3400 Spruce Street, Philadelphia, PA 19104, USA

  4. 4

    The Liver Unit, Birmingham Children's Hospital NHS Trust, Steelhouse Lane, Birmingham, B4 6NH, UK

  5. 5

    Division of Nephrology, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Hunn-319, Boston, MA 02115, USA

Author Information

  1. Division of Nephrology, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Hunn-319, Boston, MA 02115, USA

Publication History

  1. Published Online: 5 MAY 2009
  2. Published Print: 24 JAN 2007

ISBN Information

Print ISBN: 9781405124072

Online ISBN: 9781444312720

SEARCH

Keywords:

  • post-transplant lymphoproliferative disorder (PTLD);
  • end-stage renal disease (ESRD);
  • continuous cycling peritoneal dialysis (CCPD);
  • thymoglobulin;
  • polyclonal antibodies;
  • calcineurin inhibitors;
  • mycophenolate mofetil;
  • tacrolimus;
  • TOR inhibitors

Summary

This chapter contains sections titled:

  • Special Issues about Pediatrics

  • Protocols for Specific Organ Systems

  • Induction Immunosuppression

  • Maintenance Immunosuppression

  • Immunosuppression Combinations

  • Treatment of Rejection

  • Conclusions

  • References